Capital Group Private Client Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Capital Group Private Client Services's BMY Position: Q1 2026 in Review
Capital Group Private Client Services sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 43,470 shares — an estimated $2.34M sold.
Capital Group Private Client Services first reported a position in BMY in Q1 2022 and held it in 16 quarters. The position peaked at $135M in Q1 2024. 2,538 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Capital Group Private Client Services reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Capital Group Private Client Services sold 43,470 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.34M.
- Capital Group Private Client Services first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 16 quarters.
- Capital Group Private Client Services's Bristol-Myers Squibb position peaked at $135M in Q1 2024.
- 2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Capital Group Private Client Services's 13F filing for Q1 2026, filed 13 May 2026.